BCAL Diagnostics

BCAL Diagnostics Liabilities

The The Liabilities of BCAL Diagnostics (BDX.AX) as of Oct 17, 2026 is 3.69 M AUD. In the previous year, The Liabilities was 3.68 M AUD — a change of 0.29% (higher).

Liabilities

3.69 MAUD

YoY

0.29%

Last updated:

In 2025, BCAL Diagnostics's total liabilities amounted to 3.69 M AUD, a 0.29% difference from the 3.68 M AUD total liabilities in the previous year.

The BCAL Diagnostics Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
641,900.00 AUD
Jan 1, 2019
52,100.00 AUD
Jan 1, 2020
380,600.00 AUD
Jan 1, 2021
525,600.00 AUD
Jan 1, 2022
950,400.00 AUD
Jan 1, 2023
3.16 M AUD
Jan 1, 2024
3.68 M AUD
Jan 1, 2025
3.69 M AUD
The BCAL Diagnostics Liabilities history
YEARLiabilitiesYoY
3.69 MAUD+0.29%
3.68 MAUD+16.46%
3.16 MAUD+232.22%
950,400.00AUD+80.82%
525,600.00AUD+38.10%
380,600.00AUD+630.52%
52,100.00AUD-91.88%
641,900.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing BCAL Diagnostics's Liabilities

BCAL Diagnostics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating BCAL Diagnostics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing BCAL Diagnostics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

BCAL Diagnostics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in BCAL Diagnostics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about BCAL Diagnostics stock

The Liabilities of BCAL Diagnostics is 3.69 M AUD in 2025.

The Liabilities of BCAL Diagnostics changed from 3.68 M AUD to 3.69 M AUD, representing a 0.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's BCAL Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — BCAL Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BCAL Diagnostics